STUDY PROTOCOL
Accepted on 15 Jul 2025
Total Neoadjuvant Chemoradiotherapy plus anti PD-1 for Mid-to-Low Locally Advanced Rectal Cancer: Study Protocol of a prospective, Single Arm, Phase Ⅱ Study (STARS -RC06)
doi 10.3389/fonc.2025.1594927
- 143 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel anti-cancer drugs combination radio-immunotherapy strategy: new frontiers in cancer immunotherapy
Novel anti-cancer drugs combination radio-immunotherapy strategy: new frontiers in cancer immunotherapy
849
Total downloads
5,394
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 04 Jul 2025
Immuno-protective impact and clinical translation of radioprotective agents in cancer radiotherapy
doi 10.3389/fimmu.2025.1610296
- 613 views
ORIGINAL RESEARCH
Published on 23 Jun 2025
BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study
doi 10.3389/fimmu.2025.1618110
- 938 views
MINI REVIEW
Published on 13 May 2025
Ultrasound-assisted immunotherapy for malignant tumour
doi 10.3389/fimmu.2025.1547594
- 1,216 views
ORIGINAL RESEARCH
Published on 08 May 2025
Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma
doi 10.3389/fonc.2025.1567504
- 1,017 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: